Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Gastroenterology
Published in: Current Treatment Options in Gastroenterology 4/2017

01-12-2017 | Stomach (DA Johnson, Section Editor)

Current Management of Benign Epithelial Gastric Polyps

Authors: Antonio R. Cheesman, MD, David A. Greenwald, MD, Shailja C. Shah, MD

Published in: Current Treatment Options in Gastroenterology | Issue 4/2017

Login to get access

Opinion statement

Purpose of review Benign epithelial gastric polyps, although typically asymptomatic, are identified incidentally on upper endoscopy in up to 23% of patients. These include fundic gland, hyperplastic, and adenomatous polyps. Their appropriate characterization is critical as some have malignant potential, may be indicative of a gastric mucosal field defect, or may be related to an underlying polyposis syndrome. This review will discuss the current management of benign epithelial gastric polyps.
Recent findings Association of gastric polyps with proton pump inhibitor use, Helicobacter pylori infection, risk of malignant transformation, and association with polyposis syndromes have been the focus of recent literature.
Summary All symptomatic polyps, polyps larger than 1 cm in size, and polyps later found to contain dysplasia or cancer should be completely removed. Additionally, random biopsies from the intervening non-polypoid mucosa should be obtained. Finally, identification of multiple polyps of fundic gland type and/or concomitant dysplasia should raise suspicion for an underlying polyposis syndrome and prompt appropriate workup. Surveillance is generally only indicated if there is confirmed dysplasia and/or carcinoma within the polyp itself or if preneoplastic changes are identified in the non-polypoid gastric mucosa.
Literature
1.
Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88(10):1711–3.PubMed
2.
Archimandritis A, Spiliadis C, Tzivras M, Vamvakousis B, Davaris P, Manika Z, et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol. 1996;28(7):387–90.PubMed
3.
Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157(3):747–54.PubMedPubMedCentralCrossRef
4.
Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol. 2003;36(5):399–402.PubMedCrossRef
5.
Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(9):1341–8.PubMedCrossRef
6.
Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.PubMedCrossRef
7.
8.
Voutilainen M, Mantynen T, Kunnamo I, Juhola M, Mecklin JP, Farkkila M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol. 2003;38(1):109–13.PubMedCrossRef
9.
Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterology. 1998;45(20):579–82.PubMed
10.
Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci. 2003;48(7):1292–7.PubMedCrossRef
11.
Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54(12):2617–22.PubMedCrossRef
12.
Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol. 2003;9(10):2236–9.PubMedPubMedCentralCrossRef
13.
Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B, British Society of G. The management of gastric polyps. Gut. 2010;59(9):1270–6.PubMedCrossRef
14.
Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91(4):714–7.PubMed
15.
Muehldorfer SM, Stolte M, Martus P, Hahn EG, Ell C, Multicenter Study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut. 2002;50(4):465–70.PubMedPubMedCentralCrossRef
16.
Han AR, Sung CO, Kim KM, Park CK, Min BH, Lee JH, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liv. 2009;3(4):271–5.CrossRef
17.
Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep. 2011;13(6):532–9.PubMedCrossRef
18.
Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39(2):161–3.PubMedCrossRef
19.
Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26(8):659–65.PubMedCrossRef
20.
Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996;27(9):896–903.PubMedCrossRef
21.
Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7(8):849–54.PubMedCrossRef
22.
Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2013;11(11):1374–84.CrossRef
23.
• Levy MD, Bhattacharya B. Sporadic fundic gland polyps with low-grade dysplasia: a large case series evaluating pathologic and immunohistochemical findings and clinical behavior. Am J Clin Pathol. 2015;144(4):592–600. Studied over 35,000 patients with FGPs and drew a case series of those with dysplasia, with specific attention to morphological and immunohistochemical characteristics in addition to follow-up endoscopic findingsPubMedCrossRef
24.
• Nam SY, Park BJ, Ryu KH, Nam JH. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps. Euro J Gastroenterol Hepatol. 2016;28(4):449–54. Large cohort study looking at the association of H.pylori infection and its eradication on the identification and fate of gastric polyps
25.
26.
Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22(3):293–8.PubMedCrossRef
27.
Jalving M, Koornstra JJ, Gotz JM, van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Euro J Gastroenterol Hepatol. 2003;15(11):1229–33.CrossRef
28.
Stolte M, Vieth M, Ebert MP. High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Euro J Gastroenterol Hepatol. 2003;15(11):1153–6.CrossRef
29.
Zelter A, Fernandez JL, Bilder C, Rodriguez P, Wonaga A, Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011;56(6):1743–8.PubMedCrossRef
30.
Zea-Iriarte WL, Sekine I, Itsuno M, Makiyama K, Naito S, Nakayama T, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci. 1996;41(2):377–86.PubMedCrossRef
31.
Arnason T, Liang WY, Alfaro E, Kelly P, Chung DC, Odze RD, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014;65(3):353–62.PubMedCrossRef
32.
Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2(8666):783–5.PubMedCrossRef
33.
Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102(6):1980–2.PubMedCrossRef
34.
Odze RD, Quinn PS, Terrault NA, Vivona AA, Ward MA, Cohen Z, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993;24(4):442–8.PubMedCrossRef
35.
Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology. 1997;113(2):659–63.PubMedCrossRef
36.
Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998;85(6):742–50.PubMedCrossRef
37.
Hofgartner WT, Thorp M, Ramus MW, Delorefice G, Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol. 1999;94(8):2275–81.PubMedCrossRef
38.
Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004;99(4):681–6.PubMedCrossRef
39.
Sekine S, Shimoda T, Nimura S, Nakanishi Y, Akasu T, Katai H, et al. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol. 2004;17(11):1421–6.PubMedCrossRef
40.
Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):180–5.PubMedCrossRef
41.
Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Path. 2001;158(3):1005–10.PubMedPubMedCentralCrossRef
42.
Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440(4):381–6.PubMedCrossRef
43.
Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Path. 2002;161(5):1735–42.PubMedPubMedCentralCrossRef
44.
Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807–14.PubMedCrossRef
45.
Bouguen G, Manfredi S, Blayau M, Dugast C, Buecher B, Bonneau D, et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum. 2007;50(10):1612–7.PubMedCrossRef
46.
Abraham SC. Fundic gland polyps: common and occasionally problematic lesions. Gastroenterol Hepatol (N Y). 2010;6(1):48–51.
47.
Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61(5):774–9.PubMedCrossRef
48.
Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Human Genet. 2016;98(5):830–42.CrossRef
49.
Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85.e1-10.PubMedCrossRef
50.
Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Austral. 1992;157(4):287–8.PubMed
51.
52.
el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92(10):1858–60.PubMed
53.
Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110(5):615–21.PubMedCrossRef
54.
•• Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(12):1706–19.e5. Major systematic review and meta-analyses on the use of PPIs and their association with an increased likelihood of identification of FGPs on EGDPubMedCrossRef
55.
Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122(10):896–903.PubMedCrossRef
56.
Palmer RH. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(5):790.PubMedCrossRef
57.
Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116(5):716–20.PubMedCrossRef
58.
Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60
59.
Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60
60.
Morais DJ, Yamanaka A, Zeitune JM, Andreollo NA. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol. 2007;44(1):14–7.PubMedCrossRef
61.
Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52(1):105–9.PubMedCrossRef
62.
Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25(4):500–7.PubMedCrossRef
63.
Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22(40):8883–91.PubMedPubMedCentralCrossRef
64.
Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998;129(9):712–5.PubMedCrossRef
65.
Ljubicic N, Banic M, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, et al. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Euro J Gastroenterol Hepatol. 1999;11(7):727–30.CrossRef
66.
Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Wastroenterol. 2006;12(11):1770–3.CrossRef
67.
Suzuki S, Ohkusa T, Shimoi K, Horiuchi T, Fujiki K, Takashimizu I. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Gastrointest Endosc. 1997;46(6):566–8.PubMedCrossRef
68.
Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96(9):2796–7.PubMedCrossRef
69.
Ohkusa T, Miwa H, Hojo M, Kumagai J, Tanizawa T, Asaoka D, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68(2–3):57–62.PubMedCrossRef
70.
Horvath B, Pai RK. Prevalence of Helicobacter pylori in gastric hyperplastic polyps. Int J Surg Pathol. 2016;24(8):704–8.PubMedCrossRef
71.
Kumar A, Quick CR, Carr-Locke DL. Prolapsing gastric polyp, an unusual cause of gastric outlet obstruction: a review of the pathology and management of gastric polyps. Endoscopy. 1996;28(5):452–5.PubMedCrossRef
72.
Ahn JY, Son DH, Choi KD, Roh J, Lim H, Choi KS, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc. 2014;80(6):1005–13.e2.PubMedCrossRef
73.
Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial. BMC Gastroenterol. 2012;12:17.PubMedPubMedCentralCrossRef
74.
Varis O, Laxen F, Valle J. Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS. 1994;102(10):759–64.PubMedCrossRef
75.
Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.PubMedCrossRef
76.
Gonzalez-Obeso E, Fujita H, Deshpande V, Ogawa F, Lisovsky M, Genevay M, et al. Gastric hyperplastic polyps: a heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol. 2011;35(5):670–7.PubMedCrossRef
77.
Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009;6(6):331–41.PubMedCrossRef
78.
Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol. 1990;85(12):1629–34.PubMed
79.
Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38(4):481–4.PubMedCrossRef
80.
Rosen S, Hoak D. Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosc. 1993;39(6):830–3.PubMedCrossRef
81.
Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Possible neoplastic transformation within gastric hyperplastic polyp. Application of endoscopic polypectomy. Surg Endosc. 1995;9(6):714–8.PubMedCrossRef
82.
Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am JGastroenterol. 1995;90(12):2152–9.
83.
Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115(2):224–34.PubMedCrossRef
84.
Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448(1):80–4.PubMedCrossRef
85.
Park DY, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med. 2008;132(4):633–40.PubMed
86.
87.
Dang S, McElreath DP, Kumar S, Kakati B, Atiq M, Morton WJ, et al. Giant gastric hyperplastic polyp: not always a benign lesion. J Ark Med Soc. 2010;107(5):89–92.PubMed
88.
Kang HM, Oh TH, Seo JY, Joen TJ, Seo DD, Shin WC, et al. Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps. Kor J Gastroenterol. 2011;58(4):184–9.CrossRef
89.
Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol. 2011;28(4):941–4.PubMedCrossRef
90.
Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, et al. Malignant transformation of hyperplastic gastric polyps: an immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7(5):1459–63.PubMedPubMedCentral
91.
Committee ASoP, Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1–8.CrossRef
92.
Markowski AR, Guzinska-Ustymowicz K. Gastric hyperplastic polyp with focal cancer. Gastroenterol Rep (Oxf). 2016;4(2):158–61.CrossRef
93.
Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.PubMedCrossRef
94.
Committee ASoP, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.CrossRef
95.
Cao H, He N, Song S, Xu M, Piao M, Yan F, et al. Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps? PLoS One. 2015;10(4):e0122996.PubMedPubMedCentralCrossRef
96.
Lewin KJ. Nomenclature problems of gastrointestinal epithelial neoplasia. Am J Surg Pathol. 1998;22(9):1043–7.PubMedCrossRef
97.
Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol. 1997;28(2):127–33.PubMedCrossRef
98.
Schmitz JM, Stolte M. Gastric polyps as precancerous lesions. Gastrointest Endosc Clin N Am. 1997;7(1):29–46.PubMed
99.
Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc. 2000;52(1):27–32.PubMedCrossRef
100.
Tomasulo J. Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer. 1971;27(6):1346–55.PubMedCrossRef
101.
Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50(11):2496–503.PubMedCrossRef
102.
Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol. 1994;25(10):994–1005.PubMedCrossRef
103.
Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer. 1994;74(11):2896–907.PubMedCrossRef
104.
Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–8.PubMedCrossRef
105.
Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24(2):167–76.PubMedCrossRef
106.
Rugge M, Nitti D, Farinati F, di Mario F, Genta RM. Non-invasive neoplasia of the stomach. Euro J Gastroenterol Hepatol. 2005;17(11):1191–6.CrossRef
107.
Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(8):620–6.PubMedCrossRef
108.
Choi CW, Kang DH, Kim HW, Park SB, Kim S, Cho M. Endoscopic submucosal dissection as a treatment for gastric adenomatous polyps: predictive factors for early gastric cancer. Scand J Gastroenterol. 2012;47(10):1218–25.PubMedCrossRef
109.
Sakurai U, Lauwers GY, Vieth M, Sawabe M, Arai T, Yoshida T, et al. Gastric high-grade dysplasia can be associated with submucosal invasion: evaluation of its prevalence in a series of 121 endoscopically resected specimens. Am J Surg Pathol. 2014;38(11):1545–50.PubMedCrossRef
110.
Facciorusso A, Antonino M, Di Maso M, Muscatiello N. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6(11):555–63.PubMedPubMedCentralCrossRef
111.
Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc. 2016;83(6):1176–83.PubMedCrossRef
112.
Kim SY, Sung JK, Moon HS, Kim KS, Jung IS, Yoon BY, et al. Is endoscopic mucosal resection a sufficient treatment for low-grade gastric epithelial dysplasia? Gut Liver. 2012;6(4):446–51.PubMedPubMedCentralCrossRef
113.
Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2):436–50.PubMedPubMedCentralCrossRef
Metadata
Title
Current Management of Benign Epithelial Gastric Polyps
Authors
Antonio R. Cheesman, MD
David A. Greenwald, MD
Shailja C. Shah, MD
Publication date
01-12-2017
Publisher
Springer US
Published in
Current Treatment Options in Gastroenterology / Issue 4/2017
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-017-0159-6

Other articles of this Issue 4/2017

Current Treatment Options in Gastroenterology 4/2017 Go to the issue

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern

Pancreas (V Chandrasekhara, Section Editor)

Pancreatic Cancer Screening

Stomach (DA Johnson, Section Editor)

Best Practice Recommendations for Diagnosis and Management of Helicobacter pylori—Synthesizing the Guidelines

Motility (H Parkman and R Schey, Section Editors)

Diabetes and the Stomach

Stomach (DA Johnson, Section Editor)

Endoscopic Evaluation/Management of Bariatric Surgery Complications

Stomach (DA Johnson, Section Editor)

Endoscopic Treatments for Obesity

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits